SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
7605<i> I'm worried about the aftermath.</i> I've spoken to a cBiomaven-6/21/2004
7604<<Do you think we will get an announcement at the end of the 14 day responrkrw-6/21/2004
7603<i>Anyone else worried about the cost of the estorra launch?</i> Yejayhawk969-6/21/2004
7602Anyone else worried about the cost of the estorra launch? Seeing what a debacle rkrw-6/21/2004
7601Tight correlation then a notable divergence between sepr and nbix starting arounrkrw-6/18/2004
7600Tom, Since you've pointed to two of your sepracor regurgitations, take thisrkrw-6/16/2004
7599<i>What would have prevented one or more marketers of generic albuterol frBiomaven-6/16/2004
7598<<The FDA now has 14 days within which to evaluate the submission to deterquidditch-6/16/2004
7597Ahhh, that is what I didn't realize: in effect, the change from the CFC-basquidditch-6/16/2004
7596<i>So where is the re-filing? It's no longer "late May or early Jtom pope-6/16/2004
7595<i>How does publication of the FDA's Proposed Reg for Comment alter thBiomaven-6/16/2004
7594<<i>On a price-level playing field there is absolutely no reason to useFiloF-6/15/2004
7593Peter, I'm trying to figure out the linkage here. <<This notice is bequidditch-6/15/2004
7592From the FDA: <i>June 9, 2004 Media Inquiries: 301-827-6242 Consumer InqBiomaven-6/15/2004
7591Research Update biotechstocksignals.comTom Ronk-6/15/2004
7590They have also released a lot of "study" information including extendejayhawk969-6/14/2004
7589<i>How do we know that they haven't filed yet?</i> Because IBiomaven-6/14/2004
7588>>But clearly this re-filing has dragged out longer than they had anticipaIcebrg-6/14/2004
7587So where is the re-filing? It's no longer "late May or early June."Biomaven-6/14/2004
7586From Forbes: >>06.14.04, 11:32 AM ET Morgan Stanley raised estimates ontuck-6/14/2004
7585Presentation to Philly Sleep Conference of 12-month data: ir.thomsonfn.com quiquidditch-6/10/2004
7584I don't think this would be necessarily linked to approvable issues. The tybio_kruncher-6/8/2004
7583New Research Report on SEPR biotechstocksignals.comTom Ronk-6/8/2004
7582See bold emphasis, is this new, I do not recall seeing this before, if so is it jayhawk969-6/8/2004
7581General Mills is an example of a company where (at least a few years back which Biomaven-6/6/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News